Plethora Solutions


The proprietary intellectual property rights relating to Fortacin™ include patents, patent applications, know-how, regulatory data, and regulatory approvals.

Under agreements with Shionogi for collaboration and commercialisation of Fortacin™, Plethora Solutions Ltd, Plethora Therapeutics Ltd and Plethora Solutions Holdings plc (together the Plethora Group) has undertaken development of Fortacin™ and sought regulatory approval of Fortacin™. Plethora Solutions Ltd owns all regulatory data relating to Fortacin™ as well as the regulatory approval which has been granted by the EMA for Europe. Plethora Solutions Ltd will own the regulatory approvals in all other territories when granted. Since 2011, the Plethora Group has had responsibility for regulatory and commercial development of Fortacin™ in Europe, plus certain other territories, and from August 2013 this responsibility was extended to throughout the world.

Commercialisation partners would benefit from the grant of a licence from Plethora Solutions Ltd of the relevant regulatory approval for the specific territory, plus a licence of intellectual property from Shionogi for the specific territory. Shionogi and the Plethora Group have entered into a revenue sharing arrangement in relation to the commercialisation of Fortacin™, with Plethora receiving the majority proportion.

The Premature Ejaculation Bothersome Evaluation Questionnaire (PEBEQ™) is a proprietary tool which can be used by the physicians to address the multi-dimensional concept of bothersomeness experienced by men with premature ejaculation. The contents of all materials of the PEBEQ™ questionnaire are the property of Plethora Solutions Holdings PLC and are protected by copyright, trademark and other intellectual property laws. Any such content may not be reproduced, downloaded, disseminated, published, or transferred in any form or by any means, except with the prior written permission of Plethora Solutions Holdings PLC and with express attribution to Plethora Solutions Holdings PLC. Copyright infringement is a violation of federal law subject to criminal and civil penalties. PEBEQ™ is a trademark of Plethora Solutions Holdings PLC.

This Product is a proprietary development stage pharmaceutical although the European MAA has been authorized by the European Commission. Information contained on this website is provided for business development and investor relations purposes only. Patients who suffer or believe they suffer from PE should contact their physician in the first instance.